The necessity of nuclear reactors for targeted radionuclide therapies

16Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Nuclear medicine has been contributing towards personalized therapies. Nuclear reactors are required for the working horses of both diagnosis and treatment, i.e., Tc-99m and I-131. In fact, reactors will remain necessary to fulfill the demand for a variety of radionuclides and are essential in the expanding field of targeted radionuclide therapies for cancer. However, the main reactors involved in the global supply are ageing and expected to shut down before 2025. Therefore, the fields of (nuclear) medicine, nuclear industry and politics share a global responsibility, faced with the task to secure future access to suitable nuclear reactors. At the same time, alternative production routes should be industrialized. For this, a coordinating entity should be put into place. © 2013 Elsevier Ltd.

Cite

CITATION STYLE

APA

Krijger, G. C., Ponsard, B., Harfensteller, M., Wolterbeek, H. T., & Nijsen, J. W. F. (2013, July). The necessity of nuclear reactors for targeted radionuclide therapies. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2013.04.007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free